These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33643384)

  • 21. N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma.
    Sun J; Ping Y; Huang J; Zeng B; Ji P; Li D
    Front Cell Dev Biol; 2021; 9():705962. PubMed ID: 34422827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VIRMA contributes to non-small cell lung cancer progression via N
    Xu Y; Chen Y; Yao Y; Xie H; Lu G; Du C; Cheng J; Zhou J
    Cancer Lett; 2021 Dec; 522():142-154. PubMed ID: 34520821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma.
    Zhao Z; Ju Q; Ji J; Li Y; Zhao Y
    Front Mol Biosci; 2022; 9():842833. PubMed ID: 35223996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIAA1429/VIRMA promotes breast cancer progression by m
    Li N; Zhu Z; Deng Y; Tang R; Hui H; Kang Y; Rana TM
    EMBO Rep; 2023 Oct; 24(10):e55506. PubMed ID: 37705505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of mRNA m
    Li J; Yang X; Qi Z; Sang Y; Liu Y; Xu B; Liu W; Xu Z; Deng Y
    Cell Biosci; 2019; 9():66. PubMed ID: 31452869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma.
    Li J; Rao B; Yang J; Liu L; Huang M; Liu X; Cui G; Li C; Han Q; Yang H; Cui X; Sun R
    Front Oncol; 2020; 10():769. PubMed ID: 32582536
    [No Abstract]   [Full Text] [Related]  

  • 27.
    Mo P; Xie S; Cai W; Ruan J; Du Q; Ye J; Mao J
    J Int Med Res; 2020 Sep; 48(9):300060520951405. PubMed ID: 32972288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
    Liu T; Li C; Jin L; Li C; Wang L
    Med Sci Monit; 2019 Dec; 25():9435-9445. PubMed ID: 31823961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A newly defined risk signature, consisting of three m
    Fan L; Lin Y; Lei H; Shu G; He L; Yan Z; Rihan H; Yin G
    Aging (Albany NY); 2020 Sep; 12(18):18453-18475. PubMed ID: 32950970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
    Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
    Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer.
    Wang S; Zou X; Chen Y; Cho WC; Zhou X
    Front Genet; 2020; 11():580036. PubMed ID: 33584787
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis and identification of m
    Huang H; Cui X; Qin X; Li K; Yan G; Lu D; Zheng M; Hu Z; Lei D; Lan N; Zheng L; Yuan Z; Zhu B; Zhao J
    Mol Ther Nucleic Acids; 2022 Mar; 27():577-592. PubMed ID: 35036067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the HNRNPA2B1/
    Sun M; Shen Y; Jia G; Deng Z; Shi F; Jing Y; Xia S
    J Cancer; 2023; 14(7):1242-1256. PubMed ID: 37215455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HNRNPC mediated m
    Zhang M; Huang N; Gao Y; Feng Z; Kang B; Guo H; Jiang J; Liao S; Wang H
    J Reprod Immunol; 2023 Dec; 160():104160. PubMed ID: 37857158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a m
    Chen Y; Xia L; Peng Y; Wang G; Bi L; Xiao X; Li C; Li W
    Front Oncol; 2022; 12():947808. PubMed ID: 36303829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.
    Xiang S; Liang X; Yin S; Liu J; Xiang Z
    Am J Transl Res; 2020; 12(5):1789-1806. PubMed ID: 32509177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Impact of
    Guo W; Huai Q; Wan H; Guo L; Song P; Gao S; He J
    DNA Cell Biol; 2021 Feb; 40(2):316-331. PubMed ID: 33493403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
    Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
    J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Identification of Critical m
    Xu J; Liu Y; Liu J; Xu T; Cheng G; Shou Y; Tong J; Liu L; Zhou L; Xiao W; Xiong Z; Yuan C; Chen Z; Liu D; Yang H; Liang H; Chen K; Zhang X
    Front Genet; 2020; 11():602485. PubMed ID: 33343639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.